Stephan O. Krause, PhD Bristol Myers Squibb

Stephan O. Krause, PhD, is the Executive Director, Analytical Science and Technology, Cell Therapy Global Quality, at Bristol Myers Squibb.  He is an accomplished advocate for advancing industry best practices. He is currently a member of PDA’s Borard of Directors, chair of PDA’s ATMP Advisory Board, and chair of the ANSI task force (ANS-007) for analytical lifecycle steps. He has won numerous innovation, advocating, and publication awards. Based on his work and leadership, Stephan was invited and presented an industry perspective to major regulatory agencies for the analytical lifecycle and control strategies to support the implementation of ICH Q2(R2), Q12, and Q14.